Tango Therapeutics Inc
Tango Therapeutics Inc (TNGX) Implied Volatility Current
TNGX implied volatility is 85%. IV Rank is 14%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking TNGX implied volatility helps you identify when options premiums on Tango Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Tango Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when TNGX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Tango Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For TNGX, tracking metrics like TNGX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on TNGX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer.
The company was founded in 2017 and is based in Cambridge, Massachusetts.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where TNGX implied volatility sits today versus where it has been. Our scanner ranks Tango Therapeutics Inc implied volatility against its historical range, surfaces extremes in TNGX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Tango Therapeutics Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 24, 2026
Trade options with IV on your side
Track TNGX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→